🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hamlet BioPharma AB (publ) (XSAT:HAMLET.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.08
+0.10 (1.67%)
At close: Sep 30, 2026

Hamlet BioPharma AB Income Statement

Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Other Revenue
0-0.21-2.349.96
Revenue
0-0.21-2.349.96
Revenue Growth
-99.22%----76.53%6.97%
Gross Profit
0-0.21-2.349.96
Selling, General & Admin
44.8845.5644.8232.9322.4327.06
Other Operating Expenses
0.140.10.050.02-0.050.01
Operating Expenses
55.2355.8455.3342.5622.8827.08
Operating Income
-55.23-55.84-55.13-42.56-20.54-17.12
Interest Expense
-0.02-----0.08
Interest & Investment Income
0.230.230.470.720.1-
Currency Exchange Gain (Loss)
0.050.05-0.02--
Other Non Operating Income (Expenses)
--0-0-0-
Pretax Income
-54.96-55.56-54.65-41.82-20.44-17.2
Net Income
-54.96-55.56-54.65-41.82-20.44-17.2
Net Income to Common
-54.96-55.56-54.65-41.82-20.44-17.2
Net Income Growth
------
Shares Outstanding (Basic)
-186178168112111
Shares Outstanding (Diluted)
-186178168112111
Shares Change
-4.78%5.91%49.74%1.37%9.57%
EPS (Basic)
--0.30-0.31-0.25-0.18-0.16
EPS (Diluted)
--0.30-0.31-0.25-0.18-0.16
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-46.84-44.63-38.85-36.28-29.59-20.32
Free Cash Flow Per Share
--0.24-0.22-0.22-0.26-0.18
Gross Margin
100.00%-100.00%-100.00%100.00%
Operating Margin
-3400971.30%--26497.83%--878.36%-171.87%
Profit Margin
-3384540.46%--26270.61%--874.19%-172.63%
Free Cash Flow Margin
-2884350.49%--18676.37%--1265.39%-203.95%
EBITDA
-44.69-45.38-44.66-32.95-20.04-17.11
EBITDA Margin
------171.78%
D&A For EBITDA
10.5410.4610.469.60.50.01
EBIT
-55.23-55.84-55.13-42.56-20.54-17.12
EBIT Margin
------171.87%
Revenue as Reported
0.060.050.210.032.429.98